Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-24

FDA Approved: ISOTRETINOIN — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for isotretinoin by Actavis Pharma, Inc. for the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISOTRETINOIN (Isotretinoin)

Snippet

SUPPL AP for ISOTRETINOIN (ISOTRETINOIN)